Multus Revenue and Competitors

London, London

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Multus's estimated annual revenue is currently $1.8M per year.(i)
  • Multus's estimated revenue per employee is $77,500

Employee Data

  • Multus has 23 Employees.(i)
  • Multus grew their employee count by 92% last year.

Multus's People

NameTitleEmail/Phone
1
Co-founder & CTOReveal Email/Phone
2
Co-Founder & CEOReveal Email/Phone
3
Head FormulationsReveal Email/Phone
4
Head Ingredients (R&D)Reveal Email/Phone
5
Media Research ScientistReveal Email/Phone
6
Research ScientistReveal Email/Phone
7
Research TechnicianReveal Email/Phone
8
Research Scientist (Analytical Chemistry)Reveal Email/Phone
9
Research ScientistReveal Email/Phone
10
Subgroup Lead - FormulationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M1623%N/AN/A
#2
$11.8M7621%N/AN/A
#3
$1.8M2335%N/AN/A
#4
$2.2M2961%N/AN/A
#5
$1.8M2335%N/AN/A
#6
$0.9M129%N/AN/A
#7
$0.1M10%N/AN/A
#8
$18.3M118-3%N/AN/A
#9
$0.5M620%N/AN/A
#10
$4.8M6241%N/AN/A
Add Company

What Is Multus?

Mammalian cells are used to produce a myriad of products, ranging from vaccines and pharmaceuticals to tissue-transplants and disease models. However, the costliness of growing cells has become a bottleneck for companies looking to innovate healthcare and food industries. The status-quo for growing these cells is to use animal-based growth media. This is not only extremely expensive but is varied in quality and unethically sourced. Most cell culture media require young mammals to be slaughtered to extract this precious concoction. We plan to tackle these problems by engineering a new growth medium that is both inexpensive and animal-free.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$1.8M

Revenue (est)

92%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M235%N/A
#2
$3.5M23-18%N/A
#3
$1.6M23-38%$4.9M
#4
$3.3M23-57%N/A
#5
$1.6M23-12%N/A